Aberdeen Group
CHRS icon

Aberdeen Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Aberdeen Group’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,259
Closed -$188K – 960
2020
Q3 		$188K Buy
+10,259
New +$188K ﹤0.01% 924